KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addus HomeCare (ADUS) Gains from Sales and Divestitures (2016 - 2025)

Addus HomeCare (ADUS) has disclosed Gains from Sales and Divestitures for 15 consecutive years, with $103000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Gains from Sales and Divestitures rose 8.42% year-over-year to $103000.0, compared with a TTM value of $103000.0 through Dec 2024, up 8.42%, and an annual FY2024 reading of $103000.0, up 8.42% over the prior year.
  • Gains from Sales and Divestitures was $103000.0 for Q4 2024 at Addus HomeCare, up from $95000.0 in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $103000.0 in Q4 2024 and bottomed at $74000.0 in Q4 2022.
  • Average Gains from Sales and Divestitures over 5 years is $85000.0, with a median of $77000.0 recorded in 2020.
  • The sharpest move saw Gains from Sales and Divestitures fell 2.63% in 2022, then grew 28.38% in 2023.
  • Year by year, Gains from Sales and Divestitures stood at $77000.0 in 2020, then dropped by 1.3% to $76000.0 in 2021, then decreased by 2.63% to $74000.0 in 2022, then increased by 28.38% to $95000.0 in 2023, then rose by 8.42% to $103000.0 in 2024.
  • Business Quant data shows Gains from Sales and Divestitures for ADUS at $103000.0 in Q4 2024, $95000.0 in Q4 2023, and $74000.0 in Q4 2022.